Makerere University College of Health Sciences (MakCHS), Department of Pharmacology & Therapeutics in collaboration with the University of Liverpool (UoL) received funding from the UK Medical Research Council to build research capacity in Drug Safety Research in Uganda. This project seeks to develop a robust research programme to strengthen local capacity to identify and address the challenges of drug use and safety and promote the translation of research findings into policy and practice in collaboration with National Drug Authority – Uganda and UK’s Medicines and Healthcare products Regulatory Agency. Research modalities will span the clinical, biomedical, epidemiological, social sciences, implementation science, and policy-related disciplines. In particular, the program will prioritize the fields of pharmacovigilance, pharmacoepidemiology, clinical pharmacology, pharmacogenomics, clinical medicine concerning drug use and safety, aspects of social sciences that address drug use and safety, and other disciplines within the realm of drug use and safety. Key areas include the use of mHealth tools to promote drug safety, adverse drug reactions, adverse events following immunization, medication errors, patterns of drug/medication use, antimicrobial resistance, substandard and falsified medicines, and other drug-related issues.

Purpose

Applications are invited for a Manuscript Writing Workshop. It will be an intensive program that requires a significant commitment of time and effort before, during, and after the workshop. The goal is for all workshop participants to complete a research manuscript and submit it to a PubMed-listed peer-reviewed journal within 3 months. Interested applicants must complete and submit their applications to drugsafetyuganda@gmail.com by 21 February 2024. For any inquiries, call +256770464957.

Selection

Applications will be reviewed and scored and the applicant might be required to provide additional information by responding to subsequent questions within 1 week. Successful applicants will receive an official invitation to participate. This will be a highly competitive process and the workshop will be limited to the best candidates.

Timelines

The key deadlines are as follows:

1.     21 February 2024: Initial application due

2.     28 February 2024: Initial review of applications due and feedback sent to applicants

3.     6 March 2024: Responses/revised applications due

4.     9 March 2024: Final scoring and invitations sent to successful applicants

Eligibility criteria

Please carefully review the eligibility criteria below. In particular, note that only candidates who have completed all research data collection will be eligible for this workshop. Applicants with draft manuscripts, theses/dissertations, research reports, etc will have a competitive advantage. Also, note that if you are selected, you will be assigned senior faculty to work closely with you during and after the workshop to help you finalize your paper. These faculty mentors are expected to fulfill all the four ICMJE authorship criteria listed here:

http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

Therefore, you will also be expected to include your assigned writing workshop mentors as co-authors on your paper. 

Please ensure that you acknowledge your agreement to all of the workshop requirements in the application below.